Genmab A/S Analysis
| Analyst Ratings |
|
Average Target Price
|
43.30
|
|
Average Rating
|
3.40
|
|
# Strong Buys
|
2
|
|
# Buys
|
2
|
|
# Holds
|
5
|
|
# Sells
|
0
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
0.13
|
0.00
|
-0.13
|
-100.00%
|
|
2022-12-31
|
0.36
|
0.00
|
-0.36
|
-100.00%
|
|
2022-09-30
|
1.65
|
0.53
|
-1.12
|
-67.88%
|
|
2022-06-30
|
1.55
|
0.41
|
-1.14
|
-73.55%
|
|
2022-03-31
|
0.91
|
0.11
|
-0.80
|
-87.91%
|
|
2021-12-31
|
5.30
|
0.17
|
-5.13
|
-96.79%
|
|
2021-09-30
|
0.13
|
0.21
|
0.08
|
59.70%
|
|
2021-06-30
|
0.07
|
0.08
|
0.01
|
10.65%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
1.05
|
|
2021-12-31
|
0.73
|
|
2020-12-31
|
8.15
|
|
2019-12-31
|
4.86
|
|
2018-12-31
|
0.36
|
|
2017-12-31
|
0.30
|
|
2016-12-31
|
0.95
|
|
2015-12-31
|
1.31
|
|
2014-12-31
|
1.10
|
|
2013-12-31
|
0.46
|
|
2012-12-31
|
-0.08
|
|
2011-12-31
|
-0.72
|
|
2010-12-31
|
-0.83
|
|
2009-12-31
|
-0.24
|